3322 (3322) Fair Value & Analysis

Consumer Cyclical · Market cap HK$234M

3 3322 3322 · HK

PriceHK$0.1820

Fair ValueHK$0.2612

Upside+43.5%

Quality47/100

Watch 3322 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.1977 – HK$0.3365

Fair value as of: Jul 2, 2026

From 13 valuation models · updated today

Share price −9.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1700 – HK$0.2480 · fair‑value band HK$0.1977 – HK$0.3365 · the HK$0.1820 price screens below the HK$0.2612 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

3322 (3322) currently trades at HK$0.1820, while our model-based Fair Value estimate is HK$0.2612 — implying the stock looks roughly 43.5% undervalued today. We read business quality at 47/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 3322 generated revenue of HK$3.4B at a net margin of -5.4%. Revenue declined 1.1% year over year. It earns a return on equity of -1.9%. Net debt stands at HK$420M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$3.4B

Revenue growth (YoY) -1.1%

Net margin -5.4%

Return on equity -1.9%

Free cash flow HK$105M FY2025

Operating margin 1.7%

More key figures

EPS (TTM) HK$-0.0300

EPS growth (YoY) -37.9%

Net debt HK$420M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

3322 reported revenue of HK$3.4B in FY2025 versus HK$4.1B in FY2021, a compound −4.7%/yr. Reported net income was −HK$183M in FY2025.

Revenue −4.7%/yr

FY21 HK$4.1B

FY22 HK$4.1B

FY23 HK$3.1B

FY24 HK$4.0B

FY25 HK$3.4B

Net income

FY21 −HK$66.4M

FY22 HK$10.1M

FY23 −HK$375M

FY24 −HK$68.4M

FY25 −HK$183M

Is 3322 fairly valued? → Check now

Similar stocks

6 more Apparel Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
H & M Hennes & Mauritz AB HNNMY	$3.58	$3.95	+10%
Ralph Lauren Corporation RL	$366.55	$365.78	-0%
Moncler S.p.A MONC	€53.84	€38.28	-29%
Gildan Activewear Inc GIL	$52.09	$33.02	-37%
LPP SA LPP	21,720 PLN	18,670 PLN	-14%
Levi Strauss & Co LEVI	$22.53	$56.56	+151%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 3322 (3322) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.2612 versus a price of HK$0.1820 — about +44% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 3322?

Our model-based fair value for 3322 is HK$0.2612 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1820.

What is the quality score of 3322?

3322 has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 3322 (3322)?

3322 reported trailing-twelve-month revenue of about HK$3.4B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 3322?

The net profit margin of 3322 is about -5.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.